{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Orlando",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90204",
      "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy",
      "address_1": "6700 Conroy Rd Ste 155",
      "address_2": "",
      "postal_code": "32835-3515",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands",
      "recall_number": "D-0909-2022",
      "product_description": "T-105 Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL, Packaged as a) 2.5 mL Multi-Dose vial NDC 73198-0005-03; b) 5 mL Multi Dose vial, NDC 73198-0005-05, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835",
      "product_quantity": "3312 vials",
      "reason_for_recall": "Lack of assurance of sterility.",
      "recall_initiation_date": "20220509",
      "center_classification_date": "20220525",
      "report_date": "20220601",
      "code_info": "Lots: K41J09, K41I09 BUD: 11/9/2022; B24B22-22 BUD: 2/22/2023",
      "more_code_info": ""
    }
  ]
}